Browse CATs

Browse CATs  internal medicine  cardiology  atrial fibrillation

Diagnosis Economics Harm/ aetiology Prognosis Therapy Anticoagulation Cardioversion Rate control Maintenance

Atrial fibrillation paroxysmal or chronic: amiodarone maintained sinus rhythm better than sotalol but caused more adverse effects Level of evidence 1b Expiry Date November 2003 Atrial fibrillation paroxysmal or persistent: many antiarrhythmic agents can help maintain sinus rhythm Level of evidence 1a Expiry Date November 2003 Atrial fibrillation paroxysmal or persistent: no antiarrhythmic agents is clearly better than another for maintaining sinus rhythm Level of evidence 1a Expiry Date November 2003 Atrial fibrillation, supraventricular arrhythmias propafenone reduced symptomatic arrhythmias Level of evidence 2b Expiry Date November 2003 Atrial fibrillation paroxysmal: propafenone was more effective than quinidine at controlling attacks. Level of evidence 1b Expiry Date November 2003 Atrial fibrillation Maze surgery seemed effective. Level of evidence 4 Expiry Date November 2003 Atrial fibrillation chronic: disopyramide maintained sinus rhythm for at least 6 months post-cardioversion. Level of evidence 1b Expiry Date November 2003 Atrial fibrillation chronic, paroxsymal: no clear difference between propafenone and sotalol for controlling symptoms. Level of evidence 1b- Expiry Date November 2003 Atrial fibrillation paroxysmal: no clear benefit from digoxin Level of evidence 1b- Expiry Date November 2003 Atrial fibrillation quinidine helps maintain sinus rhythm but increases mortality following cardioversion. Level of evidence 1a Expiry Date November 2003 Atrial fibrillation paroxysmal, chronic: amiodarone prevented reversion better than sotalol following cardioversion. Level of evidence 1b Expiry Date November 2003 Atrial fibrillation paroxysmal: fewer patients stopped flecainide than quinidine. Level of evidence 1b Expiry Date February 2003 Atrial fibrillation, atrial flutter paroxysmal: sotalol 120 mg twice daily reduced recurrent symptomatic episodes. Level of evidence 1b Expiry Date January 2004 Atrial fibrillation amiodarone prevents recurrence than sotalol or propafenone Level of evidence 1b Expiry Date April 2004